Evidence matters

Ever since its launch in 2009, BMJ Best Practice has been at the forefront of delivering high-quality evidence that informs clinical practice worldwide. We achieve this through our rigorous and continuous evidence-based editorial processes, as well as the well-structured, consistent and intuitive way in which key evidence and relevant resources are displayed for instant use at the point of care.

In January 2017, we launched an additional resource within BMJ Best Practice through a partnership with Cochrane Clinical Answers. We now incorporate Cochrane Clinical Answers into our topics to give health professionals the confidence to make the best decisions in partnership with patients, even in areas of clinical uncertainty.

Cochrane Clinical Answers distil the essential information from Cochrane systematic reviews into a short question and answer, ideal for use at the point of care. Evidence is displayed in a user friendly format, mixing narrative, numbers and graphics along with key data including Population, Intervention, Comparison, Outcome and GRADE summaries.

Our in-house evidence team continues to collaborate with over 1,600 international expert authors and over 2,500 peer reviewers, to ensure that BMJ Best Practice provides access to the best available information possible, in line with our robust evidence processes that include:

  • Systematic searches for high quality new and updated international guidelines
  • Continuous in-house scanning and triaging of drug alerts
  • Daily monitoring and triaging of user/customer feedback by our Senior Clinical Editor
  • External peer review of all new topics by at least 2 leading international experts and practising clinicians
  • Internal peer review and sign-off for all content by in-house pharmacist and clinical editors
  • Updated daily, together with information about the changes made